The evaluation of peptide recognition defined by IFN-γ production – as a result from tumor mutanome analysis either in the format of synthetic peptides or as minigenes – can be used to gauge for biological activity in TIL as proficiency assay to gauge for T-cell reactivity against commonly strongly expressed mutant or non-mutant tumor associated antigens (290). The gene discussed is IFNG; the disease is neoplasm.